BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28341739)

  • 1. Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay.
    Ballmer BA; Moos R; Liberali P; Pelkmans L; Hornemann S; Aguzzi A
    J Biol Chem; 2017 May; 292(20):8356-8368. PubMed ID: 28341739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
    Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
    PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an intracellular site of prion conversion.
    Marijanovic Z; Caputo A; Campana V; Zurzolo C
    PLoS Pathog; 2009 May; 5(5):e1000426. PubMed ID: 19424437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular distribution of the prion protein in sickness and in health.
    Godsave SF; Peters PJ; Wille H
    Virus Res; 2015 Sep; 207():136-45. PubMed ID: 25683509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein.
    Magalhães AC; Silva JA; Lee KS; Martins VR; Prado VF; Ferguson SS; Gomez MV; Brentani RR; Prado MA
    J Biol Chem; 2002 Sep; 277(36):33311-8. PubMed ID: 12070160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell biological studies of the prion protein.
    Harris DA
    Curr Issues Mol Biol; 1999; 1(1-2):65-75. PubMed ID: 11475702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation.
    Kiachopoulos S; Heske J; Tatzelt J; Winklhofer KF
    Traffic; 2004 Jun; 5(6):426-36. PubMed ID: 15117317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
    Norstrom EM; Mastrianni JA
    J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions disturb post-Golgi trafficking of membrane proteins.
    Uchiyama K; Muramatsu N; Yano M; Usui T; Miyata H; Sakaguchi S
    Nat Commun; 2013; 4():1846. PubMed ID: 23673631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP
    Hiller H; Yang C; Beachy DE; Kusmartseva I; Candelario-Jalil E; Posgai AL; Nick HS; Schatz D; Atkinson MA; Wasserfall CH
    Diabetologia; 2021 Oct; 64(10):2279-2291. PubMed ID: 34274990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
    Rigter A; Bossers A
    J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
    Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
    J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of glypican-1 autoprocessing in scrapie infection.
    Löfgren K; Cheng F; Fransson LA; Bedecs K; Mani K
    Eur J Neurosci; 2008 Sep; 28(5):964-72. PubMed ID: 18717736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
    Shim SY; Karri S; Law S; Schatzl HM; Gilch S
    Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
    Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
    Viruses; 2019 May; 11(5):. PubMed ID: 31083283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region.
    Perera WS; Hooper NM
    Curr Biol; 2001 Apr; 11(7):519-23. PubMed ID: 11413003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
    Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.